The mammalian CPSF73 is a target of a compound (JTE-607) that is active against acute myeloid leukemia and Ewings sarcoma cell lines, and acts by mimicking RNA binding at the CPSF73 active site [24,25]. This evidence concerns the gene CPSF3 and Ewing sarcoma.